http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2424554-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1316fbeb8cf19b2b7a392bfef8436ae
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
filingDate 2002-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4710af12f2b8c3f0878198c847f1f9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebdbaeee10e498ef189badbf2ef4214d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b3877e6ff86246131617d6c10765193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_291df020d6b312517cd01ec5093bd5a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdd52101574a6611d3d88967852cb9d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4ce4e5d03ef93dd00ff48e03d99802a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdb91e27df9448567a6cd17940f769c1
publicationDate 2009-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2424554-C
titleOfInvention Antacid and laxative tablet
abstract An antacid and laxative tablet comprising magnesium oxide particles as an effective component, wherein (i) the magnesium oxide particles contained in the tablet have an average secondary particle diameter measured by a laser diffraction scattering method of 0.5 to 10 µm, (ii) the content of magnesium oxide particles in the tablet is 88 wt% or more, (iii) the tablet does not become blackish and has substantially no tableting spot, and (iv) the disintegration time is 10 sec or less. The antacid and laxative tablet of the present invention has a high content of magnesium oxide particles, a short disintegration time, does not become blackish, has no tablet trouble and no tableting spot and is suitably administered orally.
priorityDate 2001-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14792
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453459427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71308271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365

Total number of triples: 44.